Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Knowledge Management Implementation

April 1, 2012

The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.

Empire State Drug Development

March 2, 2012

An architectural wonder teaches the biopharmaceutical industry a valuable lesson in project management.

Considerations in Biopharmaceutical Outsourcing

March 2, 2012

Because of the complexity of the manufacturing processes for biologics, transfer of these processes to a contract manufacturer presents challenges.

Meeting Challenges in Contract R&D

March 2, 2012

Representatives from leading CROs weigh in on key challenges tied to the biopharmaceutical R&D, including issues regarding bioequivalence, platform technologies, process analytics, and more.

Communications Advances Present Challenges to Manufacturers

March 1, 2012

Social media use raises questions about applying old standards to new information technology.

A 25-Year Retrospective on the Public's Perception of the Biopharmaceutical and Biotech Industry

March 1, 2012

This month, we rewind to an article titled "Demystifying the New Biology."

Playing the Drug-Development Game

March 1, 2012

Key technical considerations when developing a clinical project in the biotech world.

Putting Risk-Based Decision-Making Where It Belongs

March 1, 2012

Focusing on how risk affects the entire organization can improve the business bottom line.

FDA Guides the Way to Biosimilars in the US

March 1, 2012

Has the long-awaited guidance answered all of the industry's questions?

ADVERTISEMENT

ADVERTISEMENT

Click here